Brief Summary: Primary Objective: To evaluate the efficacy of sarilumab in patients with giant cell arteritis (GCA) as assessed by the proportion of patients with sustained remission for sarilumab compared to placebo, in combination with a corticosteroid (CS) tapering course. Secondary Objective: To demonstrate the efficacy of sarilumab in patients…...
VF Celebrates Vasculitis Awareness Month 2018
The Vasculitis Foundation, the world’s largest organization dedicated to providing advocacy, education and support for people with vasculitis, announces the launch of Vasculitis Awareness Month (May 2018), an annual effort to create global awareness of the disease that’s so rare that fewer than 200,000 new cases are diagnosed each year.…...
Introducing our 2017-2018 VCRC-VF Fellow
Kaitlin Quinn, MD, is the recipient of the 2017 VCRC-VF Fellowship. She received her medical degree from New York Medical College in Valhalla, New York. She completed her Internal Medicine residency and a two-year Rheumatology fellowship training program at MedStar Georgetown University Hospital in Washington, D.C. Dr. Quinn is currently…...
